Skip to main content
. 2021 Jul 4;24(1):76–83. doi: 10.1007/s12094-021-02671-0

Fig. 4.

Fig. 4

Cumulative overall survival (OS) curves of patients with pancreatic body/tail adenocarcinoma/carcinoma or infiltrating duct carcinoma, the sub-stratification analysis in surgery alone group, and surgery plus radiotherapy group with a log-rank test, which demonstrated a sub-population of patients that benefited from additional radiotherapy. Top row (a, c, e, g), before matching. Bottom row (b, d, f, h), after matching